Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02427893
Title Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

melanoma

Therapies

Cobimetinib

Vemurafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field